Stephen Barker
Stock Analyst at Jefferies
(3.52)
# 2,179
Out of 4,408 analysts
104
Total ratings
44.4%
Success rate
8.5%
Average return
Main Sectors:
Stocks Rated by Stephen Barker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 7747 Asahi Intecc Co., Ltd. | Maintained: Buy | ¥4,200 → ¥4,500 | $3,525.00 | +27.66% | 8 | May 29, 2026 | |
| TYO: 4528 Ono Pharmaceutical Co., Ltd. | Maintained: Hold | ¥1,800 → ¥2,500 | $2,269.00 | +10.18% | 3 | May 29, 2026 | |
| TYO: 4523 Eisai Co., Ltd. | Maintained: Hold | ¥5,000 → ¥4,000 | $3,827.00 | +4.52% | 9 | May 28, 2026 | |
| TYO: 7733 Olympus Corporation | Upgraded: Buy | ¥1,700 → ¥2,300 | $1,696.00 | +35.61% | 4 | May 18, 2026 | |
| TYO: 4519 Chugai Pharmaceutical Co., Ltd. | Maintained: Hold | ¥9,100 → ¥8,500 | $7,459.00 | +13.96% | 7 | May 12, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Reiterated: Buy | ¥4,600 → ¥3,100 | $2,548.00 | +21.66% | 13 | May 6, 2026 | |
| TYO: 8086 Nipro Corporation | Maintained: Hold | ¥1,500 | $1,660.00 | -9.64% | 1 | Apr 30, 2026 | |
| TYO: 4578 Otsuka Holdings Co., Ltd. | Reiterated: Buy | ¥12,500 | $10,230.00 | +22.19% | 10 | Apr 26, 2026 | |
| TYO: 2160 GNI Group Ltd. | Maintained: Buy | ¥3,600 → ¥3,800 | $2,492.00 | +52.49% | 3 | Apr 3, 2026 | |
| TYO: 4503 Astellas Pharma Inc. | Maintained: Buy | ¥1,500 → ¥2,800 | $2,156.50 | +29.84% | 7 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥3,300 → ¥1,500 | $1,419.00 | +5.71% | 3 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,100 → ¥2,700 | $1,421.50 | +89.94% | 9 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,500 → ¥3,000 | $2,391.00 | +25.47% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥1,900 → ¥1,700 | $1,902.50 | -10.64% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥7,400 → ¥2,500 | $2,783.50 | n/a | 3 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥3,400 → ¥4,100 | $3,980.00 | n/a | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥560 → ¥660 | $454.00 | n/a | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ¥320 | $254.00 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,350 → ¥3,500 | $2,236.00 | n/a | 4 | Sep 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥4,800 → ¥5,000 | $5,086.00 | n/a | 4 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥2,700 | $930.30 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥3,600 | $3,950.00 | n/a | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $588.30 | n/a | 1 | Feb 1, 2019 |
Asahi Intecc Co., Ltd.
May 29, 2026
Maintained: Buy
Price Target: ¥4,200 → ¥4,500
Current: $3,525.00
Upside: +27.66%
Ono Pharmaceutical Co., Ltd.
May 29, 2026
Maintained: Hold
Price Target: ¥1,800 → ¥2,500
Current: $2,269.00
Upside: +10.18%
Eisai Co., Ltd.
May 28, 2026
Maintained: Hold
Price Target: ¥5,000 → ¥4,000
Current: $3,827.00
Upside: +4.52%
Olympus Corporation
May 18, 2026
Upgraded: Buy
Price Target: ¥1,700 → ¥2,300
Current: $1,696.00
Upside: +35.61%
Chugai Pharmaceutical Co., Ltd.
May 12, 2026
Maintained: Hold
Price Target: ¥9,100 → ¥8,500
Current: $7,459.00
Upside: +13.96%
Daiichi Sankyo Company, Limited
May 6, 2026
Reiterated: Buy
Price Target: ¥4,600 → ¥3,100
Current: $2,548.00
Upside: +21.66%
Nipro Corporation
Apr 30, 2026
Maintained: Hold
Price Target: ¥1,500
Current: $1,660.00
Upside: -9.64%
Otsuka Holdings Co., Ltd.
Apr 26, 2026
Reiterated: Buy
Price Target: ¥12,500
Current: $10,230.00
Upside: +22.19%
GNI Group Ltd.
Apr 3, 2026
Maintained: Buy
Price Target: ¥3,600 → ¥3,800
Current: $2,492.00
Upside: +52.49%
Astellas Pharma Inc.
Mar 24, 2026
Maintained: Buy
Price Target: ¥1,500 → ¥2,800
Current: $2,156.50
Upside: +29.84%
Mar 16, 2026
Maintained: Hold
Price Target: ¥3,300 → ¥1,500
Current: $1,419.00
Upside: +5.71%
Dec 15, 2025
Maintained: Buy
Price Target: ¥2,100 → ¥2,700
Current: $1,421.50
Upside: +89.94%
Sep 10, 2025
Maintained: Buy
Price Target: ¥2,500 → ¥3,000
Current: $2,391.00
Upside: +25.47%
Aug 8, 2025
Downgraded: Hold
Price Target: ¥1,900 → ¥1,700
Current: $1,902.50
Upside: -10.64%
Oct 25, 2024
Maintained: Hold
Price Target: ¥7,400 → ¥2,500
Current: $2,783.50
Upside: n/a
Oct 21, 2024
Maintained: Hold
Price Target: ¥3,400 → ¥4,100
Current: $3,980.00
Upside: n/a
Sep 11, 2024
Maintained: Hold
Price Target: ¥560 → ¥660
Current: $454.00
Upside: n/a
Sep 9, 2024
Upgraded: Buy
Price Target: ¥320
Current: $254.00
Upside: n/a
Sep 2, 2024
Maintained: Buy
Price Target: ¥3,350 → ¥3,500
Current: $2,236.00
Upside: n/a
Aug 13, 2024
Maintained: Buy
Price Target: ¥4,800 → ¥5,000
Current: $5,086.00
Upside: n/a
Aug 1, 2024
Maintained: Hold
Price Target: ¥2,700
Current: $930.30
Upside: n/a
Jul 30, 2024
Maintained: Hold
Price Target: ¥3,600
Current: $3,950.00
Upside: n/a
Feb 1, 2019
Upgraded: Buy
Price Target: n/a
Current: $588.30
Upside: n/a